Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Liesa Regner-Nelke

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
BMC Neurology|July 3, 2023
Bilateral vocal cord palsy as complication of CNS tuberculosisLiesa Regner-Nelke, Bendix Labeit, Christopher Nelke, et al.
International Journal of Molecular Sciences|September 28, 2021
Enjoy Carefully: The Multifaceted Role of Vitamin E in Neuro-NutritionLiesa Regner-Nelke, Christopher Nelke, Christina B Schroeter, et al.
Neurological Research and Practice|December 29, 2022
Myositis in Germany: epidemiological insights over 15 years from 2005 to 2019Marc Pawlitzki, Laura Acar, Lars Masanneck, et al.
Multiple Sclerosis and Related Disorders|June 14, 2022
Detecting ongoing disease activity in mildly affected multiple sclerosis patients under first-line therapiesLars Masanneck, Leoni Rolfes, Liesa Regner-Nelke, et al.
Frontiers in Immunology|January 9, 2023
Vaccine-based clinical protection against SARS-CoV-2 infection and the humoral immune response: A 1-year follow-up study of patients with multiple sclerosis receiving ocrelizumabSaskia Räuber, Alice Willison, Melanie Korsen, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|March 5, 2022
Eculizumab versus rituximab in generalised myasthenia gravisChristopher Nelke, Christina B Schroeter, Frauke Stascheit, et al.
Journal of Autoimmunity|January 9, 2023
Cerebrospinal fluid proteomics indicates immune dysregulation and neuronal dysfunction in antibody associated autoimmune encephalitisSaskia Räuber, Christina B Schroeter, Christine Strippel, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|February 23, 2022
Immune response to SARS-CoV-2 vaccination in relation to peripheral immune cell profiles among patients with multiple sclerosis receiving ocrelizumabSaskia Räuber, Melanie Korsen, Niklas Huntemann, et al.
Neurological Research and Practice|November 6, 2022
Real-world evidence on siponimod treatment in patients with secondary progressive multiple sclerosisLiesa Regner-Nelke, Marc Pawlitzki, Alice Willison, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
BMC Neurology|July 3, 2023
Bilateral vocal cord palsy as complication of CNS tuberculosisLiesa Regner-Nelke, Bendix Labeit, Christopher Nelke, et al.
International Journal of Molecular Sciences|September 28, 2021
Enjoy Carefully: The Multifaceted Role of Vitamin E in Neuro-NutritionLiesa Regner-Nelke, Christopher Nelke, Christina B Schroeter, et al.
Neurological Research and Practice|December 29, 2022
Myositis in Germany: epidemiological insights over 15 years from 2005 to 2019Marc Pawlitzki, Laura Acar, Lars Masanneck, et al.
Multiple Sclerosis and Related Disorders|June 14, 2022
Detecting ongoing disease activity in mildly affected multiple sclerosis patients under first-line therapiesLars Masanneck, Leoni Rolfes, Liesa Regner-Nelke, et al.
Frontiers in Immunology|January 9, 2023
Vaccine-based clinical protection against SARS-CoV-2 infection and the humoral immune response: A 1-year follow-up study of patients with multiple sclerosis receiving ocrelizumabSaskia Räuber, Alice Willison, Melanie Korsen, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|March 5, 2022
Eculizumab versus rituximab in generalised myasthenia gravisChristopher Nelke, Christina B Schroeter, Frauke Stascheit, et al.
Journal of Autoimmunity|January 9, 2023
Cerebrospinal fluid proteomics indicates immune dysregulation and neuronal dysfunction in antibody associated autoimmune encephalitisSaskia Räuber, Christina B Schroeter, Christine Strippel, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|February 23, 2022
Immune response to SARS-CoV-2 vaccination in relation to peripheral immune cell profiles among patients with multiple sclerosis receiving ocrelizumabSaskia Räuber, Melanie Korsen, Niklas Huntemann, et al.
Neurological Research and Practice|November 6, 2022
Real-world evidence on siponimod treatment in patients with secondary progressive multiple sclerosisLiesa Regner-Nelke, Marc Pawlitzki, Alice Willison, et al.
Pageof 1